Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.26 USD | +4.89% | -4.70% | -15.53% |
01:04pm | Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16 | MT |
May. 02 | RBC Capital Reviews Bausch + Lomb's Q1 Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.53% | 4.78B | |
-4.24% | 184B | |
-0.80% | 108B | |
-3.26% | 67.82B | |
+3.92% | 51.05B | |
+8.81% | 44.67B | |
+3.40% | 41.78B | |
+2.83% | 26.78B | |
+4.00% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb P Introduces "Enhanced" Eye Vitamin Formulation In U.S.